Role of anti-angiogenic factor endostatin in the pathogenesis of experimental ulcerative colitis

Life Sciences

Volumn 88, Issue 1-2, 2011, Pages 74-81

  Tolstanova, Ganna ^a,f   Deng, Xiaoming ^a,b   Khomenko, Tetyana ^a,b   Garg, Pallavi ^d   Paunovic, Brankica ^a   Chen, Longchuan ^a   Sitaraman, Shanthi V ^d   Shiloach, Joseph ^e   Szabo, Sandor ^a,b   Sandor, Zsuzsanna ^a,c  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

Author keywords

Endostatin; Matrix metalloproteinase 9; Ulcerative colitis; VEGF

Indexed keywords

DEXTRAN SULFATE; ENDOSTATIN; GELATINASE B; INTERLEUKIN 10; IODOACETAMIDE; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT ENDOSTATIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON INJURY; CONTROLLED STUDY; DEFENSE MECHANISM; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FEMALE; KNOCKOUT MOUSE; MORPHOLOGY; MOUSE; NONHUMAN; PATHOGENESIS; RAT; ULCERATIVE COLITIS; UPREGULATION; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; COLITIS, ULCERATIVE; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; ENDOSTATINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IODOACETAMIDE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; PLATELET-DERIVED GROWTH FACTOR; RATS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MUS; RATTUS;

EID: 78650522483     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.10.026     Document Type: Article

References (54)

1. A. Abdollahi, P. Hahnfeldt, C. Maercker, H.J. Grone, J. Debus, and W. Ansorge Endostatin's antiangiogenic signaling network Mol Cell 13 5 2004 649 663
2. A. Abdollahi, L. Hlatky, and P.E. Huber Endostatin: the logic of antiangiogenic therapy Drug Resist Updat 8 1-2 2005 59 74
3. M.D. Baugh, M. Perry, A. Hollander, D.R. Davies, S.S. Cross, and A.J. Lobo Matrix metalloproteinases levels are elevated in inflammatory bowel disease Gastroenterology 117 4 1999 814 822
4. W.D. Beecken, T. Engl, R. Blaheta, W. Bentas, E.G. Achilles, and D. Jonas Angiogenesis inhibition by angiostatin, endostatin and TNP-470 prevents cyclophosphamide induced cystitis Angiogenesis 7 1 2004 69 73
5. D. Belotti, C. Calcagno, A. Garofalo, D. Caronia, E. Riccardi, and R. Giavazzi Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion Mol Cancer Res 6 4 2008 525 534
6. C. Bendrik, J. Robertson, J. Gauldie, and C. Dabrosin Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo Cancer Res 68 9 2008 3405 3412
7. B. Brankin, M. Campbell, P. Canning, T.A. Gardiner, and A.W. Stitt Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium Exp Eye Res 81 1 2005 22 31
8. M. Campbell, R. Collery, A. McEvoy, T.A. Gardiner, A.W. Stitt, and B. Brankin Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function Curr Eye Res 31 12 2006 1033 1045
9. P. Carmeliet Angiogenesis in health and disease Nat Med 9 6 2003 653 660
10. F.E. Castaneda, B. Walia, M. Vijay-Kumar, N.R. Patel, S. Roser, and V.L. Kolachala Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP Gastroenterology 129 6 2005 1991 2008
11. J.H. Chidlow Jr., W. Langston, J.J. Greer, D. Ostanin, M. Abdelbaqi, and J. Houghton Differential angiogenic regulation of experimental colitis Am J Pathol 169 6 2006 2014 2030
12. S. Danese, M. Sans, C.D.L. Motte, C. Graziani, G. West, and M.H. Phillips Angiogenesis as a novel component of inflammatory bowel disease pathogenesis Gastroenterology 130 7 2006 2060 2073 (Pubitemid 43816964)
13. M. Dhanabal, R. Volk, R. Ramchandran, M. Simons, and V.P. Sukhatme Cloning, expression, and in vitro activity of human endostatin Biochem Biophys Res Commun 258 2 1999 345 352
14. A. Di Sabatino, R. Ciccocioppo, L. Benazzato, G.C. Sturniolo, and G.R. Corazza Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients Aliment Pharmacol Ther 19 9 2004 1019 1024
15. A.L. Feldman, H.R. Alexander Jr., D.L. Bartlett, K.C. Kranda, M.S. Miller, and N.G. Costouros A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases Ann Surg Oncol 8 9 2001 741 745
16. A.L. Feldman, L. Tamarkin, G.F. Paciotti, B.W. Simpson, W.M. Linehan, and J.C. Yang Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer Clin Cancer Res 6 12 2000 4628 4634
17. M. Ferreras, U. Felbor, T. Lenhard, B.R. Olsen, and J. Delaissé Generation and degradation of human endostatin proteins by various proteinases FEBS Lett 486 3 2000 247 251
18. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1 1995 27 31
19. J. Folkman Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action Exp Cell Res 312 5 2006 594 607
20. V.C. Ganta, W. Cromer, G.L. Mills, J. Traylor, M. Jennings, and S. Daley Angiopoietin-2 in experimental colitis Inflamm Bowel Dis 16 6 2010 1029 1039
21. T. Griga, A. Tromm, J. Spanger, and B. May Increased serum level of vascular endothelial growth factor in patients with inflammatory bowel disease Scand J Gastroenterol 33 5 1998 504 508
22. K.P. Guan, H.Y. Ye, Z. Yan, Y. Wang, and S.K. Hou Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder Urology 61 4 2003 719 723
23. S. Kanazawa, T. Tsunoda, E. Onuma, T. Majima, M. Kagiyama, and K. Kikuchi VEGF, basic-FGF, and TGF-β in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation Am J Gastroenterol 96 3 2001 822 828
24. T. Kojima, T. Watanabe, K. Hata, and H. Nagawa Basic fibroblast growth factor enema improves experimental colitis in rats Hepatogastroenterology 54 77 2007 1373 1377
25. P. Lindahl, B.R. Johansson, P. Levéen, and C. Betsholtz Pericyte loss and microaneurysm formation in PDGF-B-deficient mice Science 277 5323 1997 242 245
26. M.F. McCarty, R.J. Somcio, O. Stoeltzing, J. Wey, F. Fan, and W. Liu Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content J Clin Investig 117 8 2007 2114 2122
27. D.M. Neskey, A. Ambesi, K.M. Pumiglia, and P.J. McKeown-Longo Endostatin and anastellin inhibit distinct aspects of the angiogenic process J Exp Clin Cancer Res 27 2008 61
28. U.W. Nilsson, and C. Dabrosin Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo Cancer Res 66 9 2006 4789 4794
29. Oikonomou KA, Kapsoritakis AN, Kapsoritaki AI, Manolakis AC, Tiaka EK, Tsiopoulos FD, et al. Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease. Inflamm Bowel Dis in press.
30. M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, and W.S. Lane Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 2 1997 277 285
31. B.C. Patterson, and Q.A. Sang Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9) J Biol Chem 272 46 1997 28823 28825
32. S. Plamondon, S.C. Ng, and M.A. Kamm Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies Aliment Pharmacol Ther 25 5 2007 557 567
33. O. Prakash, B. Medhi, U.N. Saikia, and P. Pandhi Effect of different doses of thalidomide in experimentally induced inflammatory bowel disease in rats Basic Clin Pharmacol Toxicol 103 1 2008 9 16 (Pubitemid 351874535)
34. S. Punekar, S. Zak, V.G. Kalter, L. Dobransky, I. Punekar, and J.W. Lawler Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease Pathobiology 75 1 2008 9 21
35. M.T. Salmela, T.T. MacDonald, D. Black, B. Irvine, T. Zhuma, U. Saarialho-Kere, and S.L. Pender Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation Gut 51 4 2002 540 547
36. Z.S. Sandor, M. Nagata, S. Kusstatscher, and S. Szabo New animal model of ulcerative colitis associated with depletion of glutathione and protein SH alkylation Gastroenterology 106 5 1994 A766
37. Z.S. Sandor, X.M. Deng, T. Khomenko, A.S. Tarnawski, and S. Szabo Altered angiogenic balance in ulcerative colitis: a key to impaired healing? Biochem Biophys Res Commun 350 1 2006 147 150
38. H. Satoh, F. Sato, K. Takami, and S. Szabo New ulcerative colitis model induced by SH blockers in rats and the effects of antiinflammatory drugs on the colitis Jpn J Pharmacol 73 4 1997 299 309
39. H. Satoh, A. Shino, F. Sato, S. Asano, I. Murakami, and N. Inatomi Role of endogenous basic fibroblast growth factor in the healing of gastric ulcers in rats Jpn J Pharmacol 73 4 1997 59 71
40. F. Scaldaferri, S. Vetrano, M. Sans, V. Arena, G. Straface, and E. Stigliano VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis Gastroenterology 136 2 2009 585 595
41. J. Spalinger, H. Patriquin, M.C. Miron, G. Marx, D. Herzog, and J. Dubois Doppler US in patients with Crohn disease: vessel density in the diseased bowel reflects disease activity Radiology 217 3 2000 787 791
42. S. Szabo, Z. Sandor, A. Vincze, S. Kusstatscher, and G. Sakoulas Role of basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) in ulcer healing Dig Dis Sci 41 1996 438
43. S. Szabo, and Z. Sandor Basic fibroblast growth factor and PDGF in GI diseases Baillières Clin Gastroenterol 10 1 1996 97 112
44. S. Szabo, A. Vincze, Z. Sandor, M. Jadus, Z. Gombo, and A. Pedram Vascular approach to gastroduodenal ulceration: new studies with endothelins and VEGF Dig Dis Sci 43 1998 40S 45S
45. S. Szabo, Z.S. Sandor, J. Al-Bassam, G. Singh, and A. Vincze Despite different etiologies, virtually identical changes in local bFGF, PDGF and VEGF levels in duodenal ulceration and ulcerative colitis indicate similarities in healing Gastroenterology 114 suppl 5 1998 G1228
46. S. Szabo, Z. Gombos, and Z. Sandor Growth factors in gastrointestinal diseases BioDrugs 12 1 1999 27 41
47. Y. Suzaki, K. Hamada, M. Sho, T. Ito, K. Miyamoto, and S. Akashi A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model J Allergy Clin Immunol 116 6 2005 1220 1227
48. K.A. Thatch, K.G. Mendelson, M.M. Haber, and M.Z. Schwartz Growth factor manipulation of intestinal angiogenesis: a possible new paradigm in the management of inflammatory bowel disease J Surg Res 156 2 2009 245 249
49. G. Tolstanova, X. Deng, T. Khomenko, L. Chen, Z. Sandor, and J. Fox Relationship between angiogenic and anti-angiogenic factors in the pathogenesis of inflammatory bowel disease Gut 56 2007 A50
50. G. Tolstanova, T. Khomenko, X. Deng, L. Chen, A. Tarnawski, and A. Ahluwalia Neutralizing anti-vascular endothelial growth factor (VEGF) antibody reduces severity of experimental ulcerative colitis in rats: direct evidence for the pathogenic role of VEGF J Pharmacol Exp Ther 328 3 2009 749 757
51. E.A. Vasiliauskas, L.Y. Kam, M.T. Abreu-Martin, P.V. Hassard, K.A. Papadakis, and H. Yang An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease Gastroenterology 117 6 1999 1278 1287
52. B. von Lampe, B. Barthel, S.E. Coupland, E.O. Riecken, and S. Rosewicz Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease Gut 47 1 2000 63 73
53. A. Wiercinska-Drapalo, J. Jaroszewicz, A. Parfieniuk, T.W. Lapinski, M. Rogalska, and D. Prokopowicz Pigment epithelium-derived factor in ulcerative colitis: possible relationship with disease activity Regul Pept 140 1-2 2007 1 4
54. G. Yin, W. Liu, P. An, P. Li, I. Ding, and V. Planelles Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis Mol Ther 5 5 Pt 1 2002 547 554